A precipitous step deeper into the CDMO business
23/11/20 -"Wacker's Biosolutions business has become a partner of choice for German mRNA player CureVac. Currently, the technology transfer for the production of CureVac's COVID-19 vaccine candidate is being ..."
Pages
58
Language
English
Published on
23/11/20
You may also be interested by these reports :
14/05/24
Sales in the Q1 declined as anticipated, but adjusted EBITDA demonstrated greater resilience. The figures were mixed compared to the consensus ...
14/05/24
1Q24 EBITA 24% down yoy – Full year EBITA at low end of expectations
13/05/24
SGL Carbon’s Graphite Solutions has reached its maximum capacity for semiconductor products, but additional customer down payments are helping to ...
10/05/24
REC Silicon appears to be facing multiple problems that reduce the runway and the company may reach a point where it needs some fresh money. After ...